Latest News for: delcath

Edit

Statement of Changes in Beneficial Ownership (Form 4) (Delcath Systems Inc)

Public Technologies 06 Mar 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... OMB Number ... DELCATH SYSTEMS, INC ... C/O DELCATH SYSTEMS, INC., 566 QUEENSBURY AVENUE 3 ... C/O DELCATH SYSTEMS, INC ... Delcath Systems Inc.
Edit

Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology

Business Wire 03 Mar 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH), (“Delcath” or the “Company”) an ...
Edit

CHOPIN Clinical Trial Results in The Lancet Oncology (Form 8-K) (Delcath Systems Inc)

Public Technologies 03 Mar 2026
QUEENSBURY, NY - March 3, 2026 Delcath Systems, Inc ... About Delcath Systems, Inc., HEPZATO KIT, and CHEMOSAT. Delcath Systems, Inc ... HEPZATO KIT is comprised of the chemotherapeutic drug melphalan and Delcath's proprietary HDS ... Delcath Systems Inc.
Edit

Delcath Systems Reports Fourth Quarter and Full Year 2025 Results

Business Wire 26 Feb 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH) (“Delcath” or the “Company”), an ...
Edit

Delcath Systems Reports Fourth Quarter and Full Year 2025 Results (Form 8-K) (Delcath Systems Inc)

Public Technologies 26 Feb 2026
) Delcath Systems Reports Fourth Quarter and ... QUEENSBURY, NY - February 26, 2026, Delcath Systems, Inc ... Delcath has provided in this release certain financial information that has not been prepared in accordance with GAAP ... Delcath Systems, Inc.
Edit

Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K) (Delcath Systems Inc)

Public Technologies 26 Feb 2026
) Management's Discussion and Analysis of Financial Condition and Results of Operations ... Overview. We are an interventional oncology company focused on the treatment of cancers primary or metastatic to the liver ... The FOCUS Trial ... Delcath Systems Inc.
Edit

Ocular melanoma Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Delcath System, ...

GetNews 19 Feb 2026
The Key Ocular melanoma Companies in the market include - Immunocore, Delcath Systems, IDEAYA Biosciences, Aura Biosciences, Linnaeus Therapeutics, Turnstone Biologics, Seagen, IDEAYA, Ascentage Pharma, and others ... Delcath Systems ... Delcath System.
Edit

Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call

Business Wire 12 Feb 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq ... Event Date. Th .
Edit

Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & ...

Business Wire 27 Jan 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... About Delcath Systems, Inc., HEPZATO KIT ...
Edit

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire 22 Jan 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH) (the “Company” or “Delcath”), an ...
Edit

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Delcath Systems Inc)

Public Technologies 21 Jan 2026
21, 2026-- Delcath Systems, Inc ... The RSUs are subject to the employee's continued employment with Delcath on each vesting date ... About Delcath Systems, Inc. Delcath Systems, Inc ... [email protected] ... Delcath Systems, Inc ... Delcath Systems Inc.
Edit

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results (Form 8-K) (Delcath Systems Inc)

Public Technologies 12 Jan 2026
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results. QUEENSBURY, NY - January 9, 2026, Delcath Systems, Inc ... About Delcath Systems, Inc., HEPZATO KIT and CHEMOSAT. Delcath Systems, Inc ... Delcath Systems Inc.
Edit

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

Business Wire 09 Jan 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH) (“Delcath” or the “Company”), an ...
Edit

Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic ...

Business Wire 31 Dec 2025
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH), (“Delcath” or the “Company”) an ...

Article Search

tools
×
×
×
×